Clinical study and follow-up of 100 patients withthe antiphospholipid syndrome

[1]  G. Reber,et al.  Control of Oral Anticoagulation in Patients with the Antiphospholipid Syndrome – Influence of the Lupus Anticoagulant on International Normalized Ratio , 1998, Thrombosis and Haemostasis.

[2]  S. Moll,et al.  Monitoring Warfarin Therapy in Patients with Lupus Anticoagulants , 1998, Annals of Internal Medicine.

[3]  G. Hughes,et al.  Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients , 1998, Lupus.

[4]  F. Guillemin,et al.  Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis , 1998, Lupus.

[5]  S. Looney,et al.  A Retrospective Review of 61 Patients With Antiphospholipid Syndrome: Analysis of Factors Influencing Recurrent Thrombosis , 1997 .

[6]  K. Granger,et al.  Review : Obstetric outcome in antiphospholipid syndrome , 1997 .

[7]  Z. Haskal,et al.  Antiphospholipid syndrome: patterns of life-threatening and severe recurrent vascular complications. , 1997, Radiology.

[8]  H. Cohen,et al.  Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) , 1997, BMJ.

[9]  P. D. de Groot,et al.  Lupus Anticoagulant is the Strongest Risk Factor for both Venous and Arterial Thrombosis in Patients with Systemic Lupus Erythematosus , 1996, Thrombosis and Haemostasis.

[10]  P. Valle,et al.  Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants. , 1996, Annales de medecine interne.

[11]  R. Roubey.  Immunology of the antiphospholipid antibody syndrome. , 1996, Arthritis and rheumatism.

[12]  W. Kutteh.  Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. , 1996, American journal of obstetrics and gynecology.

[13]  L. Carreras,et al.  Reactivity to β2 Glycoprotein I Clearly Differentiates Anticardiolipin Antibodies from Antiphospholipid Syndrome and Syphilis , 1996, Thrombosis and Haemostasis.

[14]  R. Derksen,et al.  Clinical manifestations and management of the antiphospholipid syndrome , 1996, Lupus.

[15]  R. Silver,et al.  Antiphospholipid Antibodies and Fetal Death , 1996, Obstetrics and gynecology.

[16]  G. Hughes,et al.  A study of sixty pregnancies in patients with the antiphospholipid syndrome. , 1996, Clinical and experimental rheumatology.

[17]  J. Brandt,et al.  Laboratory Identification of Lupus Anticoagulants: Results of the Second International Workshop for Identification of Lupus Anticoagulants , 1995, Thrombosis and Haemostasis.

[18]  H. Cohen,et al.  High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. , 1995, Human reproduction.

[19]  G. Hughes,et al.  Antiphospholipid antibodies and antiphospholipid syndrome , 1995, Current opinion in rheumatology.

[20]  G. Hughes,et al.  The management of thrombosis in the antiphospholipid-antibody syndrome. , 1995, The New England journal of medicine.

[21]  C. Kallenberg,et al.  Review : Serological markers of disease activity in systemic lupus erythematosus , 1995, Lupus.

[22]  R. Cervera,et al.  Clinicopathologic correlations of theantiphospholipid syndrome , 1995 .

[23]  F. Fabris,et al.  Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thrombocytopenia , 1994, European journal of haematology.

[24]  D. Sthoeger,et al.  The role of anticardiolipin autoantibodies in the pathogenesis of autoimmune hemolytic anemia in systemic lupus erythematosus. , 1993, The Journal of rheumatology.

[25]  J. Piette,et al.  Exclusion criteria for primary antiphospholipid syndrome. , 1993, The Journal of rheumatology.

[26]  B. Tartakovsky,et al.  Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Y. Shoenfeld,et al.  In Vitro Effect of Anticardiolipin Autoantibodies Upon Total and Pulsatile Placental hCG Secretion During Early Pregnancy , 1993, American journal of reproductive immunology.

[28]  P. Fishman,et al.  Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. , 1993, The Journal of clinical investigation.

[29]  G. Hughes,et al.  Systemic Lupus Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of 1,000 Patients , 1993 .

[30]  M. Rosove,et al.  Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients , 1992, Annals of Internal Medicine.

[31]  M. Hughson,et al.  Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  D. Balaban,et al.  Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. , 1992, American journal of obstetrics and gynecology.

[33]  M. Leirisalo-Repo,et al.  Platelet autoantibodies detected by immunoblotting in systemic lupus erythematosus: Association with the lupus anticoagulant, and with history of thrombosis and thrombocytopenia , 1990, European journal of haematology.

[34]  G. Hughes,et al.  The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features , 1989, Medicine.

[35]  J. Sánchez-Guerrero,et al.  Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. , 1989, The Journal of rheumatology.

[36]  G. Hughes,et al.  Anticardiolipin antibodies: isotype distribution and phospholipid specificity. , 1987, Annals of the rheumatic diseases.

[37]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[38]  S. Moll,et al.  Monitoring warfarin therapy in patients with lupus anticoagulants. , 1997, Annals of internal medicine.

[39]  E. Harris,et al.  Clinical and serological features of the "anti-phospholipid syndrome" (APS) , 1987 .